10.5 C
New York

Bankrupt 23andMe to be bought by pharmaceutical company Regeneron for $256 million

Published:


Regeneron Pharmaceuticals has promised to comply with 23andMe’s existing privacy polices while also using data to fuel drug discovery.



Source link

Related articles

spot_img

Recent articles

spot_img